▲ Bullish for Morepen Laboratories

Morepen Laboratories submits first ANDA to USFDA for Sitagliptin Tablets

1 source · first seen 09:16 28 Sept · updated 09:16 28 Sept

The brief

Written from 1 report · check the source before you trade

Morepen Laboratories submitted its first ANDA to USFDA for Sitagliptin Tablets
The US filing advances Morepen’s pharma pipeline, though no approval or commercial timeline is reported

Pick a tag to see all its stories

1 report · earliest 09:16